Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Breast care (Basel, Switzerland), 2006-10, Vol.1 (5), p.316-319
Ort / Verlag
Basel, Switzerland
Erscheinungsjahr
2006
Quelle
Alma/SFX Local Collection
Beschreibungen/Notizen
International and national guidelines (S3
guideline) for the surveillance of post-treatment breast
cancer patients recommend a clinical follow-up including
routine history and physical examination and regular
mammograms. The practice of a clinical follow-up has
been often discussed, but has been proven not to be inferior
when compared to an intensified follow-up in randomized
trials. Patients and Methods: The present manuscript
reports the patients’ view on the basis of a survey
including 2000 patients with a history of breast cancer.
Results: A total of 452 patients (22.6%) answered the
questionnaire. The median age was 62 years (range
23-85 years). More than 80% of the patients were disease-
free at the time of the survey. The need for surveillance
was affirmed by the majority of patients (>95%),
and one third stated that there was a need for more technical
efforts during follow-up. In contrast to the follow-up
guidelines, the results of the present survey indicated
that most of the regularly scheduled follow-up visits
were expanded using extensive laboratory and imaging
procedures. Conclusion: This survey shows that the majority
of physicians obviously do not accept the present
follow-up guidelines. A new surveillance study investigating
the efficacy of an intensified surveillance based
on the improved possibilities of modern diagnostics and
endocrine, immunotherapeutic, chemotherapeutic and
interventional treatment options is warranted.